These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33507806)

  • 1. Multiparametric MR evaluation of uterine leiomyosarcoma and STUMP versus leiomyoma in symptomatic women planned for high frequency focussed ultrasound: accuracy of imaging parameters and interobserver agreement for identification of malignancy.
    Aminzadeh P; Alibrahim E; Dobrotwir A; Paul E; Goergen S
    Br J Radiol; 2021 Mar; 94(1119):20200483. PubMed ID: 33507806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of multiparametric MRI in differentiating uterine leiomyosarcoma from benign degenerative leiomyoma and leiomyoma variants: a retrospective analysis.
    Mahmood NS; Al Rashid AA; Ladumor SB; Mohamed MA; Kambal AS; Saloum N; Mohamed SEMK; Al Hyassat S; Singh R
    Clin Radiol; 2023 Jan; 78(1):47-54. PubMed ID: 36220736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.
    Lakhman Y; Veeraraghavan H; Chaim J; Feier D; Goldman DA; Moskowitz CS; Nougaret S; Sosa RE; Vargas HA; Soslow RA; Abu-Rustum NR; Hricak H; Sala E
    Eur Radiol; 2017 Jul; 27(7):2903-2915. PubMed ID: 27921159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine smooth muscle tumours with hyperintense area on T
    Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
    Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI screening for uterine leiomyosarcoma.
    Tong A; Kang SK; Huang C; Huang K; Slevin A; Hindman N
    J Magn Reson Imaging; 2019 Jun; 49(7):e282-e294. PubMed ID: 30637854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What MRI features suspect malignant pure mesenchymal uterine tumors rather than uterine leiomyoma with cystic degeneration?
    Kim TH; Kim JW; Kim SY; Kim SH; Cho JY
    J Gynecol Oncol; 2018 May; 29(3):e26. PubMed ID: 29400019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging findings of unusual leiomyoma and malignant uterine myometrial tumors: what the radiologist should know.
    Fujii S; Mukuda N; Ochiai R; Yunaga H; Murakami A; Gonda T; Kishimoto M; Yamaji D; Ishibashi M
    Jpn J Radiol; 2021 Jun; 39(6):527-539. PubMed ID: 33517507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas.
    Al Khuri M; Al Salmi I; Al Ajmi H; Al Hadidi A; Alabousi A; Haider E; Vasudev P; Al Salmi A; Jose S; Alrahbi N
    Int J Gynecol Cancer; 2024 Jul; 34(7):1027-1033. PubMed ID: 38658016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
    Petrović D; Babić D; Forko JI; Martinac I
    Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI, clinical, and radiomic models for differentiation of uterine leiomyosarcoma and leiomyoma.
    Roller LA; Wan Q; Liu X; Qin L; Chapel D; Burk KS; Guo Y; Shinagare AB
    Abdom Radiol (NY); 2024 May; 49(5):1522-1533. PubMed ID: 38467853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
    Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
    J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic interpretation of non-contrast qualitative MR imaging features for characterisation of uterine leiomyosarcoma.
    Sahin H; Smith J; Zawaideh JP; Shakur A; Carmisciano L; Caglic I; Bruining A; Jimenez-Linan M; Freeman S; Addley H
    Br J Radiol; 2021 Sep; 94(1125):20210115. PubMed ID: 34111973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presurgical Identification of Uterine Smooth Muscle Malignancies through the Characteristic FDG Uptake Pattern on PET Scans.
    Ho KC; Dean Fang YH; Lin G; Ueng SH; Wu TI; Lai CH; Chueh HY; Chao A; Chang TC; Yen TC
    Contrast Media Mol Imaging; 2018; 2018():7890241. PubMed ID: 30018513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating leiomyosarcoma from leiomyoma: in support of an MR imaging predictive scoring system.
    Jagannathan JP; Steiner A; Bay C; Eisenhauer E; Muto MG; George S; Fennessy FM
    Abdom Radiol (NY); 2021 Oct; 46(10):4927-4935. PubMed ID: 34075468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors.
    Chen L; Yang B
    Int J Gynecol Pathol; 2008 Jul; 27(3):326-32. PubMed ID: 18580309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound features using MUSA terms and definitions in uterine sarcoma and leiomyoma: cohort study.
    De Bruyn C; Ceusters J; Vanden Brande K; Timmerman S; Froyman W; Timmerman D; Van Rompuy AS; Coosemans A; Van den Bosch T
    Ultrasound Obstet Gynecol; 2024 May; 63(5):683-690. PubMed ID: 37970762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can gray-scale and color Doppler sonography differentiate between uterine leiomyosarcoma and leiomyoma?
    Exacoustos C; Romanini ME; Amadio A; Amoroso C; Szabolcs B; Zupi E; Arduini D
    J Clin Ultrasound; 2007 Oct; 35(8):449-57. PubMed ID: 17636502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MVP immunohistochemistry is a useful adjunct in distinguishing leiomyosarcoma from leiomyoma and leiomyoma with bizarre nuclei.
    Lintel NJ; Luebker SA; Lele SM; Koepsell SA
    Hum Pathol; 2018 Mar; 73():122-127. PubMed ID: 29307622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.